202-11A8細胞 
	
		ATCC Number:	CRL-2669?
	
	
		運輸方式:	凍存運輸
	
	
		是否是腫瘤細胞:	0
	
	
		物種來源:	小鼠
	
	
		生長狀態:	懸浮生長
	
	
		細胞形態:	**樣
	
	
		**類型:	IgG1 and IgG2b
	
	
		數量:	大量
	
	
		202-11A8細胞Designations:	202-11A8
	
	
		Depositors:	 National Cancer Institute
	
	
		Isotype:	IgG1 and IgG2b
	
	
		Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	suspension
	
	
		Organism:	Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
	
	
		Morphology:	lymphoblast
	
	
		
	
	
		Source:	Cell Type: hybridoma: B lymphocyte;
	
	
		Cellular Products:202-11A8細胞 immunoglobulin; monoclonal antibody; against a synthetic SRC/YES oncogene peptide
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Comments:	Animals were immunized with a synthetic polypeptide with the sequence LGQGCFGEVWMG corresponding to peptides 276 to 287 of the SRC/YES oncogene (formerly 273 to 284).
	
	
		Spleen cells were fused with Sp2/0 myeloma cells.
	
	
		Using immunoblot techniques, the antibody recognizes proteins of 140,000, 70,000, 60,000 and 55,000 daltons.
	
	
		The IgG1 reactivity of the antibody with the src peptide (276-287) was confirmed by ELISA.
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. 202-11A8細胞To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
	
	
		Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10 exp5 viable cells/ml.
	
	
		Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml.
	
	
		Preservation:	culture medium 95%; DMSO, 5%
	
	
		Related Products:	Recommended medium 202-11A8細胞(without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
	
	
		recommended serum:ATCC 30-2020